At COMPAMED 2026 (hall 8b, booth D29), Plasmatreat is presenting an extended plasma portfolio targeting surface treatment challenges in medical device manufacturing. The company's focus covers three core process steps — cleaning, activation, and functional coating — applied to components such as catheters, ventilator masks, diagnostic systems, tubes, and implants.
A key highlight of the exhibition is what Plasmatreat describes as a world first: the simultaneous internal and external low-pressure plasma treatment of wound catheters with outer diameters down to 0.3 mm. Achieving uniform plasma exposure inside such narrow-bore geometries represents a recognised process engineering challenge, as conventional atmospheric plasma jets cannot effectively penetrate lumen dimensions at that scale. Low-pressure (vacuum) plasma chambers allow reactive species to reach interior surfaces more uniformly, making the approach relevant for thin-walled flexible tubing used in wound drainage and infusion applications.
The relevance to electronics manufacturing lies in the shared process fundamentals. Plasma surface treatment — whether atmospheric-pressure openair systems or low-pressure batch processes — is widely used in electronics for pre-bonding activation of PCB substrates, conformal coating adhesion improvement, and underfill preparation in semiconductor packaging. The same material compatibility and cleanliness requirements that apply to medical implants and drug-contact surfaces also govern advanced packaging workflows where contamination at the nanometre level affects bond-line integrity or encapsulant adhesion.
Plasmatreat positions the selection of plasma technology as dependent not solely on substrate material but on component geometry, contamination type, desired surface function, cycle time, and the downstream process step. The company states it evaluates the complete process chain — from material and component tests through parameter definition, system design, automation, and process control — before specifying a solution. This systems-level approach, rather than supplying standalone plasma units, is consistent with the direction taken by other surface-treatment suppliers integrating inline plasma modules with MES feedback loops in high-volume electronics assembly lines.
For medical device contract manufacturers and OEMs operating in Europe, the elimination of solvent-based primers and wet-chemical pretreatments is a compliance and sustainability argument. Plasma processes run without additional process chemicals, simplifying waste handling and supporting documentation requirements under MDR (EU Medical Device Regulation), where traceability of manufacturing conditions is mandatory. The same driver is increasingly present in automotive electronics and advanced packaging, where VOC reduction and dry-process preferences are reshaping pretreatment specifications.
Plasmatreat's low-pressure plasma expansion broadens a portfolio that has historically been centred on the Openair-Plasma atmospheric technology, which is well established in electronics assembly for selective activation prior to conformal coating and dispensing. The COMPAMED presentation signals the company's intent to address application segments — particularly implantables and minimally invasive device components — where atmospheric systems face geometric or cleanliness constraints.
Quelle: Plasmatreat (semicon) – https://www.plasmatreat.com/en/news-and-stories/news-and-press/detail/plasma-solutions-for-reliable-surface-treatment-processes-in-medical-technology





